Rapid onset of osteonecrosis of the jaw in patients switching from bisphosphonates to denosumab

Denosumab-induced ONJ might develop rapidly in patients previously treated with BP. ONJ developed spontaneously in most patients treated with denosumab. In light of our sample being small, there is need for further investigation on our conclusions.